Home    About Us    Medic-All    Bio B2B    Hot Topic     Expo     Login | Join Now          
Bio B2BTLC, Ltd. 〉TLC590

TLC590

TLC590

Liposomal encapsulated ropivacaine. This would effectively reduce the repeated administration of anesthetics, and resultant side effects, as well as eliminating the use of post-surgical painkillers.

Request for Collaboration
Overview
TLC590 brings sustained release delivery technology to the common anesthetic ropivacaine, with the goal of reducing the frequency of administration for local anesthesia for post-surgical pain. More effective pain relief may also allow patients to avoid the problems of opioid therapies often used for the treatment of post-surgical pain.
Application
Local anesthesia.
Advantages:
  • Sustained release of anesthetics, and reduce the frequency of administration, lowering the risk of anesthesia
  • Eliminate the use of post-surgical painkillers
  • Proprietary manufacturing process to effectively reduce the cost of production
People who like this also like
  • AmCAD CAAmCAD CA
  • PixoTest technologyPixoTest technology
  • Breast Image Matching Method and Image Processing ApparatusBreast Image Matching Method and Image Processing Apparatus
  • CX-5461-G-quadruplex stabilizerCX-5461-G-quadruplex stabilizer
  • Methylation-Specific-PCR (MSP)Methylation-Specific-PCR (MSP)
  • Complete and Comprehensive Design/Production CapabilitiesComplete and Comprehensive Design/Production Capabilities
  • GLP LaboratoriesGLP Laboratories
  • FB317FB317
  • Cancer screening by next generation sequencingCancer screening by next generation sequencing
  • FLISA (IgE/IgG test)FLISA (IgE/IgG test)